TrialBMC cancer2023

Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

Zhongjun Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.